Skip to main content

Table 2. Patient laboratory data

From: Efficacy of denosumab therapy for a 12-year-old female patient with Williams syndrome with osteoporosis and history of fractures: a case report

  Before 1 month 2 months 5 months 9 months 11 months 17 months 23 months 29 months
Alb-corrected Ca 9.4 9.5 11.0 9.6 10.0 9.8 9.6 10.4 10.6
P 4.3 3.5 4.5 4.3 3.9 3.7 4.0 4.2 3.4
BAP 38.2 44.9 36.7 44.9 20.9 35.2 30.0 18.8 23.0
PINP 404 392 286 406 341 473 374 183 230
NTX 73.5 87.6 148 322 220 282 233 1596 1276
TRACP-5b 692 353 579 1290 652 1190 997 660 939
1,25(OH)2D 188 155 103 66.7 73.3 64.1 59.6 53.0 41.8
25(OH)D 13.7 N/A N/A 20.8 22.8 25.4 24.3 20.5 20.0
Whole PTH 7.4 9.0 7.8 6.4 5.3 5.9 5.0 4.1 4.0
  1. Alb-corrected Ca albumin-corrected calcium, P phosphorus, BAP bone-specific alkaline phosphatase, PINP type I procollagen N-terminal propeptide, NTX type I collagen amino-terminal telopeptide, TRACP-5b tartrate-resistant acid phosphatase 5b, 1,25(OH)2D 1-α, 25-dihydroxyvitamin D3, 25(OH)D 25-hydroxyvitamin D3, PTH parathyroid hormone